Literature DB >> 21852233

Cellular iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genes.

Federica Saletta1, Yohan Suryo Rahmanto, Aritee R Siafakas, Des R Richardson.   

Abstract

Iron plays a crucial part in proliferation while iron deficiency results in G(1)/S arrest, DNA damage, and apoptosis. However, the precise role of iron in cell cycle control remains unclear. We showed that iron depletion using the iron chelators, desferrioxamine (DFO), or 2-hydroxy-1-napthylaldehyde isonicotinoyl hydrazone (311), increased the mRNA levels of the growth arrest and DNA damage 45α gene, GADD45α (Darnell, G. and Richardson, D. R. (1999) Blood 94, 781-792). In this study, we examined the effect of iron depletion on up-regulating GADD family members involved in growth control, including cell cycle arrest, apoptosis, and DNA repair, making them therapeutic targets for tumor suppression. We showed the GADD family members were up-regulated by cellular iron depletion. Further, up-regulation of GADD45α after iron deprivation was independent of hypoxia-inducible factor-1α (HIF-1α), octamer-1 (Oct-1), p53 and early growth response 1 (Egr1). We then analyzed the regulatory elements responsible for iron depletion-mediated regulation of GADD45α and identified the specific transcription factor/s involved. This region was within -117 bp and -81 bp relative to the start codon where the consensus sequences of three transcription factors are located: the CCAAT-binding factor/nuclear factor-Y (NF-Y), the stabilizing molecule v-MYB and the enhancer, CCAAT enhancer-binding protein (CEBPα). Mutation analysis, shRNA studies, Western blotting, and electrophoretic mobility shift assays led to the identification of NF-Y in the transcriptional up-regulation of GADD45α after iron depletion. Furthermore, like GADD45α, NF-YA was up-regulated after iron chelation and down-regulated by iron supplementation. These results are important for understanding the mechanisms of iron depletion-mediated cell cycle arrest, DNA damage repair, and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852233      PMCID: PMC3195607          DOI: 10.1074/jbc.M111.273060

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Translational control of gene expression during hypoxia.

Authors:  Twan van den Beucken; Marianne Koritzinsky; Bradly G Wouters
Journal:  Cancer Biol Ther       Date:  2006-07-01       Impact factor: 4.742

2.  Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation.

Authors:  Jolyn Turner; Constantinos Koumenis; Timothy E Kute; Roy P Planalp; Martin W Brechbiel; Dillon Beardsley; Brooke Cody; Kevin D Brown; Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

3.  Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression.

Authors:  Effie Nurtjahja-Tjendraputra; Dong Fu; Juanita M Phang; Des R Richardson
Journal:  Blood       Date:  2006-12-29       Impact factor: 22.113

Review 4.  Iron uptake and metabolism in the new millennium.

Authors:  Louise L Dunn; Yohan Suryo Rahmanto; Des R Richardson
Journal:  Trends Cell Biol       Date:  2006-12-27       Impact factor: 20.808

5.  Iron regulation and the cell cycle: identification of an iron-responsive element in the 3'-untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy.

Authors:  Mayka Sanchez; Bruno Galy; Thomas Dandekar; Peter Bengert; Yevhen Vainshtein; Jens Stolte; Martina U Muckenthaler; Matthias W Hentze
Journal:  J Biol Chem       Date:  2006-06-07       Impact factor: 5.157

6.  GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets.

Authors:  Luiz F Zerbini; Towia A Libermann
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

7.  A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics.

Authors:  Megan Whitnall; Jonathan Howard; Prem Ponka; Des R Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

8.  The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites.

Authors:  M R Campanero; A Herrero; V Calvo
Journal:  Oncogene       Date:  2007-08-27       Impact factor: 9.867

9.  An upstream open reading frame regulates translation of GADD34 during cellular stresses that induce eIF2alpha phosphorylation.

Authors:  Yun-Young Lee; Randal C Cevallos; Eric Jan
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

10.  Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion.

Authors:  Dong Fu; Des R Richardson
Journal:  Blood       Date:  2007-04-11       Impact factor: 22.113

View more
  19 in total

1.  "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening.

Authors:  Christopher J Schulze; Walter M Bray; Marcos H Woerhmann; Joshua Stuart; R Scott Lokey; Roger G Linington
Journal:  Chem Biol       Date:  2013-02-21

2.  Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2.

Authors:  Masaki Miyazawa; Alexander R Bogdan; Yoshiaki Tsuji
Journal:  Cell Chem Biol       Date:  2018-11-15       Impact factor: 8.116

3.  Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer.

Authors:  Zhiyong Deng; David H Manz; Suzy V Torti; Frank M Torti
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

Review 4.  Emerging therapeutic targets of sepsis-associated acute kidney injury.

Authors:  Sundararaman Swaminathan; Mitchell H Rosner; Mark D Okusa
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

Review 5.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

6.  Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin.

Authors:  Leman Yalcintepe; Emre Halis
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

7.  Iron Deprivation May Enhance Insulin Receptor and Glut4 Transcription in Skeletal Muscle of Adult Rats.

Authors:  A Mehdad; N A Campos; S Fernandes Arruda; E Machado de Almeida Siqueira
Journal:  J Nutr Health Aging       Date:  2015-10       Impact factor: 4.075

Review 8.  Translation initiation factors and their relevance in cancer.

Authors:  Columba de la Parra; Beth A Walters; Phillip Geter; Robert J Schneider
Journal:  Curr Opin Genet Dev       Date:  2017-11-16       Impact factor: 5.578

9.  Up-regulation of Gadd45α after exposure to metal nanoparticles: the role of hypoxia inducible factor 1α.

Authors:  Lingfang Feng; Yue Zhang; Mizu Jiang; Yiqun Mo; Rong Wan; Zhenyu Jia; David J Tollerud; Xing Zhang; Qunwei Zhang
Journal:  Environ Toxicol       Date:  2013-11-26       Impact factor: 4.119

10.  N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.

Authors:  Darius J R Lane; Federica Saletta; Yohan Suryo Rahmanto; Zaklina Kovacevic; Des R Richardson
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.